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The hepatic circulation is unique in that high volumes of low pressure blood flow are supplied through a
dual venous and arterial circulation. This vascular supply is modulated both by the gastrointestinal vascular
bed and an intrahepatic microcirculation. This complex vascular system is influenced by pathologic processes
within the liver. Alterations in the hepatic circulation reflect hepatic metabolic adaptation and injury. It seems
reasonable to assume that in some circumstances hepatic circulatory alterations are inappropriate, exagger-
ated or inadequate and contribute to the initiation or perpetuation of hepatic injury. This paper attempts to
focus on evidence derived from studies of the normal and abnormal hepatic circulation that provide insights
into hepatic circulatory responses and their role in the initiation and perpetuation of hepatic injury. A
possible relationship of these vascular changes to pathologic processes within the liver is proposed. Ulti-
mately, precise measurement and understanding of hepatic vasculature changes may allow appropriate
intervention to offset injury or stimulate maximum effective repair.
INTRODUCTION
Study of the hepatic circulation has been based upon the inkling that the hepatic
vasculature and its adaptive responses play a role in the initiation and perpetuation of
hepatic parenchymal injury. In comparison to the histopathologic study of liver
disease with its complex of intertwined aggressive and reparative factors and pro-
longed time course, the hemodynamic changes associated with liver disease provide
an opportunity to observe rapidly evolving pathophysiology and test methods for
determining prognosis, capacity for restitution and efficacy oftherapeutic maneuvers
in the entire living organ of man (Table 1) [1].
Our increasing appreciation ofhepatic vascular physiology and the development of
new technics for its study and manipulation in man make it appropriate to summar-
ize selected data and attempt to generate potentially fruitful working hypotheses. Our
aim is to define the anatomic and physiologic characteristics ofthe hepatic circulation
that play a vital role in the evolution of liver disease and its consequence, portal
hypertension, and to probe for delicate balance points from which critical forces may
be shifted.
1. Dual Hepatic Arterial and Portal Venous Circulation: The hepatic sinusoid and
its adjacent microvasculature is the site of complex anastomosis between the high
pressure, low volume hepatic arterial inflow and the low pressure, high volume portal
venous input. In prenatal life the hepatic artery alone supplies the liver. The gut is
dormant and portal blood is shunted through the ductus venosus along with maternal
umbilical venous blood into the vena cava and right atrium (Fig. 1). At birth the
umbilical vein and ductus venosus close and the liver relies largely on portal venous
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TABLE I
Pathologic Alterations of the Hepatic Circulation in Liver Disease
Normal Liver Disease
Macrocirculation
1. Portal-hepatic venous pressure gradient (mm Hg)a 5 5-30
2. Volume flow (ml/min) b 1,500 400-800
3. Fractional contribution hepatic artery/portal vein (percent)c 33/67 90/10
4. Portal venous flow (percent)d 67 0-67
5. Extraction efficiency (percent extraction)e 83±15 31-60
6. Lymph production (percent blood flow)f 0.06 1.6
7. Extrahepatic leak (percent intracellular production)9 0.1 1-50
Microcirculation
1. Autoregulation h
a. Periodicity of lobular flow Present ?
b. Synergistic arterial-portal flowd Present Impaired
2. Sinusoidal functioni
a. PermeabilityJ 400,000 mole wt. Reduced
b. Space of disse Small Enlarged
c. Hepatocyte proximityJ kJ f,m Immediate Distant
d. Numerical reduction (hepatocytes sinusoids) No Yes
e. Lobular gradientn Intact Distortion-shunts
f. Transit time0 Homogeneous Increased-decreased
g. Sphincter functionP Yes ?
a Viallet A, Joly J, Marleau D, et al: Comparison offree portal venous pressure and wedged hepatic venous pressure in
patients with cirrhosis of the liver. Gastroent 59:372-275, 1970
b Shaldon S, Chiandussi G, Guevara A, et al: The estimation ofhepatic blood flow and intrahepatic shunted blood flow
by colloidal heat-denatured human serum albumin labeled with I'3'. J Clin Invest 40:1346-1354, 1961
c Price JB, Voorhees AB, Britton RC: Operative hemodynamic studies in portal hypertension. Arch Surg 95:843-852,
1967
d Moreno AH, Burchell AR, Rousselot WF, et al: Portal blood flow in cirrhosis ofthe liver. J Clin Invest 46:436-444,
1967
e Caesar J, Shaldon S, Chiandussi L, et al: The use ofindocyanine green in the measurement ofhepatic blood flow and
as a test of hepatic function. Clin Sci 21:43-57, 1961
f Dumont AE, Mulholland JH: Alterations in thoracic duct lymph flow in hepatic cirrhosis. Ann Surg 156:668-671,
1962
g Zimmon DS, Oratz M, Kessler R, et al: Albumin to ascites: Demonstration ofa direct pathway bypassing the systemic
circulation. J Clin Invest 48:2074-2078, 1969
h Rappaport AM, Schneiderman JH: The function ofthe hepatic artery. Rev Physiol Biochem Pharmacol 76:130-159,
1976
Popper H, Elias H, Petty DE: Vascular pattern of the cirrhotic liver. Am J Clin Path 22:717-729, 1952
i Schaffner F, Popper H: Capillarization of hepatic sinusoids in man. Gastroent 44:239-246, 1963
k Fuchs WA, Preisig R, Voegeli E, et al: Hepatic arteriography in cirrhosis of the liver and portal hypertension. Invest
Radiol 7:369-377, 1972
1 Bircher J, Blankart R, Halpern A, et al: Criteria for assessment offunctional impairment in patients with cirrhosis of
the liver. Europ J Clin Invest 3:72-85, 1973
m Kelty RH, Baggenstoss AH, Butt HR: The relation of the regenerated liver nodule to the vascular bed in cirrhosis.
Gastroent 15:285-295, 1950
' Strandell T, Erwald R, Lundbergh P, et al: Estimations of lobar hepatic blood flows and extractions in severe liver
cirrhosis. Acta Med Scand 194:219-220, 1973
o Johansson L, Tornvall G: Hepaticarterial and portal venous circulation times in normals and in patients with chronic
liver injury. Acta Med Scand 168:85-94, 1960
P McCuskey RS: A dynamic and static study ofhepatic arterioles and hepatic sphincters. Am J Anat 119:455-478, 1966HEPATIC VASCULAR RESPONSE TO INJURY
FIG. IA. X-ray ofa 50%barium sulfate suspension injected through the umbilical vein into the portal venous system of
an adult human liver at post-mortem. After removing the liver from the body the suprahepatic vena cava and the portal
vein were ligated. A probe was passed through the umbilical vein across the left branch of the portal vein through the
ductus venosus into the vena cava. In life, this potentially patent channel is closed by sphincters at the umbilical-portal,
ductus venosus-portal and ductus venosus-vena caval junctions.
flow [2]. From then on portal venous blood supplies approximately two-thirds ofthe
hepatic blood flow and hepatic arterial blood the remainder. The hepatic artery
retains the capacity to compensate for changes in portal flow and constitutes an
important variable in hepatic vascular function [3]. Recent attempts to modify
metabolic function in the liver by diverting portal venous flow in patients with
glycogen storage disease [4] or hyperlipidemia [5] and ligation of the hepatic arteries
in patients with hepatic cancer [6]emphasize the ability ofthe normal liver to tolerate
acute loss ofeither hepatic arterial or portal venous flow without immediate disabil-
ity. It is suspected, however, that such major changes in quantity or quality of flow
may result in functional derangements that may become clinically apparent months
or years later. The dual character ofthe hepaticcirculation permits all or a portion of
the liver to sustain itself through either the hepatic artery or portal vein and allows
adaptation to diverse extrahepatic vascular and intrahepatic pathologic events. The
precise metabolic and morphologic consequences of these alterations remain to be
elucidated.
2. Low Resistance Hepatic Venous and Sinusoidal Systems: Resistance to flow
from portal venous to hepatic venous vessels through hepatic sinusoids is remarkably
low. In normal man the pressure gradient from portal vein to hepaticvein is less than
5 mm Hg at blood flow rates of 1500 ml per min [7,8]. A 1 mm Hg change in portal-
hepatic venous pressure gradient would accommodate a 20% (± 300 ml/min) change
in blood flow if hepatic vascular resistance were unchanged. Thus, large changes in
499R.14.-Rigt Kepo,tie
:Lit-Left Hspetke '
0. OV.-Cuti Wain .~ ~ 'r
S.P - S,tibhoc Vwn:--.';-.
FIG. IB. Drawing of barium radiography showing the umbilical vein and ductus venosus in an adult human liver at
post-mortem.
hepatic flow may occur with little change in portal pressure [8]. When one considers
that the accuracy of pressure measurement in man is ± 1 mm Hg, it is apparent that
large changes in hepatic vascular resistance may go undetected.
3. Complex Acinar Microcirculation: In lower animals transillumination studies of
the hepatic circulation in vivo demonstrate that at any instant only a fraction of the
total number of hepatic acinar vascular units are actively perfused. Some acini are
dormant with stagnant sinusoids while adjacent vascular units are actively perfused
and presumably, are also active metabolically, as uptake and excretion proceed. The
functional role of the acinar rest period is obscure. Periods of active perfusion are
complex. Blood progresses through individual sinusoids in a series of succussions
that mix the formed and fluid elements and expose the sinusoidal surface and its large
pores to a perfusate ofcontinually changing composition. Periodic spurts of hepatic
arterial blood from lateral and branch vessels accelerate sinusoidal transit and add
red cells rich in oxygen [9]. A gradient of nutrient concentration along the sinusoid
determines the metabolic activity, oxygen availability and susceptibility to injury of
the individual acinar zones of Rappaport (Figs. 2,3). Zone 1, adjacent to the portal
inflow and high in nutrients and oxygen, is most active metabolically. It is protected
from some types of injury, particularly ischemic, and is the site of regenerative
activity. In Zone III, at the acinar periphery, hepatocytes are living in a marginal
environment oflimited nutrients and oxygen, bathed in excrement. Zone III is highly
susceptible to ischemic and toxic injury. Zone II is in an intermediate position
anatomically, functionally, and in susceptibility to certain types of injury [9].
4. Interplay of Portal Venous and Acinar Microcirculation in Liver Injury: The
portal venous network is highly branched and responds with rapid changes in theHEPATIC VASCULAR RESPONSE TO INJURY
C)
FIG. 2. Hepatic acinar vascular zones as described by Rappaport. Zone I s adjacent to the portal space (P.S.) and
vascular inflow. Zone 11I holds an intermediate position. Zone 111 is at the vascular periphery ofthe acinus adjacent to the
terminal hepatic vein (T.H.V.). (Courtesy ofA.M. Rappaport, University of Toronto School of Medicine).
magnitude and direction of flow to small changes in metabolic activity, tissue
pressure and probably hepatic arterial flow [10]. In disease states this diversity offlow
patterns could allow the diversion of portal blood from damaged areas of increased
resistance to less injured areas of lower vascular resistance. This marked vascular
response to cellular injury and the complexity of hepatic acinar blood flow pattern
may explain the spotty lobular pattern of many types of hepatic injury as observed
through the extended time frame of histopathology. Acute severe hepatic injury
could cause cessation of individual acinar blood flow by impeding both the sensitive
portal and more resistant arterial flow.
Diversion of blood flow and metabolic activity to the more intact acini might
provide an efficient reserve of hepatic function for the organism acutely and could
stimulate the relatively less injured areas to undergo hypertrophy and hyperplasia
until a remodeling process is complete and adequate hepatic mass is restored. In the
long run this valuable acute response might be detrimental and perpetuate hepatic
injury since injured areas deprived ofportal flow and the accompanying hepatotropic
nutrients [11] may fail to survive injury or, if surviving the acute injury, come to
atrophy as other acinar units gain a permanent vascular advantage.
The damaged liver liberates substances that stimulate collagen synthesis [12].
Reduced local perfusion may limit removal of these factors and dispose to irreversi-
ble fibrosis.
Blood is shunted through hepatic vascular segments when injury, failure of repair
and fibrosis reduce the hepatocyte population [13,14]. Less injured areas hypertro-
phy, regenerate, and attempt to increase their fractional metabolic and vascular role.
In this proposed sequence of events the hepatic vascular and metabolic adaptive
response that preserves adequate function and allows restitution ofhepatic functional
mass after acute injury leads to the formation ofa heterogeneous organ with areas of
501DAVID S. ZIMMON
Microsomes
' -hydroxybutyrate dehydrogenose
Lactic dehydrogenose (e) -. : - (C)
ha-glycerophosphate (e'. , jTioDphorases(9) sCtat '.
tEsteroses(c Moaote (e)
-:- Cytochrome oxy ae iC) 3
Alkoline phosphatase.J)
(1 3 . --Glucose-6 phosphatase (ct)
u . . ... : Succinate dehydrogena (cse 2
0 2
... Mitochondria numerous, larger 4
Kfor Krebs cycle? : and'
1 N~ .v1~Lysosomes c ~~iret
Cytogeness
1'. S\< , j P .. Acid peptidoses(g)
DPNHandTPNH reductoses
FIG. 3. Metabolic areas of the hepatic acinus defined in terms of enzymatic patterns and metabolite accumulation.
Varied relationships to acinar blood flow result in metabolic variation within the lobule which in turn determine
enzymatic activity and sites for production and storage. (Courtesy ofA.M. Rappaport, University of Toronto Schoolof
Medicine).
hypertrophy and hyperplasia interspersed with atropic and destroyed (collapsed)
acini with adjacent fibrosis. If the process were severe, cirrhosis would be the result.
This working hypothesis emphasizes the role of vascular and blood flow mediated
metabolic processes in the perpetuation of acute liver injury and the development of
hepatic cirrhosis. It implies a need for intervention at the outset of acute liver injury
to maintain maximum portal venous perfusion (pressure) that could remove poten-
tially toxic products and supply nutrients and hepatotropic factors to stimulate repair
at the acinar level even when overall hepatic functional deficit may appear modest
and immediate survival of the organism is not in doubt. This hypothesis provides a
potential mechanism whereby empiric metabolic therapy (corticosteroids) could
favor restitution of hepatic architecture by increasing metabolic activity and acinar
blood flow [15,16].
5. Acinar Concept ofRappaport Applied to Chronic Hepatic Injury: In the normal
human liver increased volume of blood flow could be accommodated by recruitment
ofadditional acinar units and reduced flow by a reduction in the number offunction-
ing acinar units through prolongation of the individual rest periods. In this situation,
the concept of hepatic vascular resistance as the simple function of mean input
pressure divided by blood flow rate is untenable, and comparisons between the
normal liver with surplus functional mass and the heterogeneous diseased liver are
presumptive at best.
The shrinkage offunctional hepatic mass during the evolution ofliver disease may
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be conceptualized as a progressive reduction in the number of functional acini.
Initially reserve units are lost. With disease progression, a point is reached where
adequate hepatic function can be maintained with fewer acini by increasing the
period ofactivity and reducing the rest interval. With increased demands or a further
reduction in tissue mass, blood flow per unit increases. This increased acinar meta-
bolic and vascular activity may achieve a steady state and provide adequate hepatic
function. A further increase in demand or further hepatic injury would lead to
decompensation when increased blood flow or competition between substrates
yielded reduced, rather than increased hepatocyte extraction from sinusoidal blood
and accentuated overall hepatic metabolic inadequacy [17]. Alternatively, the contin-
uous demand for acinar function, both vascular and metabolic, could in itself prove
injurious, and a vicious circle ofhepatic injury and reduced hepatic function develop.
Although the consequences of disordered hepatic vascular function and reduced
tissue mass both lead to the final common pathway of reduced metabolic function,
the causes of and remedies for each of these disorders differ. Reduced hepatic
perfusion in the extreme of hypovolemic shock or congestive heart failure may
severely compromise even the normal liver [18]. The complete loss of portal venous
flow and presumed hepatotropic pancreatic factors which accompany portacaval
shunt and pancreatic extirpation for cancer may prove lethal in the presence of
normal hepatic morphology [19]. The cirrhotic liver may be more susceptible. The
cirrhotic patient, whose hepatic vascular pattern is already grosslyderanged, may not
tolerate abrupt diversion of portal flow by portacaval shunt [20,21]. A similar, but
less dramatic, decline in hepatic function may accompany the stress of anemia or
hypovolemia. Indeed, the enormous increments in serum transaminase in patients
with compromised hepatic blood flow indicate abrupt damage to the cells ofZone III.
Anemia forces the diseased liver with reduced blood flow and limited capacity for
oxygen extraction into a more hypoxic state. Partial compensation through increased
oxygen extraction occurs [22], but undoubtedly hepatocytes in the marginal environ-
ment of Zone III will suffer. Reserve hepatic function is compromised and hypertro-
phy or regeneration limited.
6. Potential Role ofPortal Perfusion Pressure in Acinar Function: Portal venous
pressure is directly proportional to blood volume [23]. Hypovolemia reduces portal
pressure. Hepatic blood flow may also be reduced indirectly through reduction of
cardiac output or its splanchnic fraction following direct changes in splanchnic
hemodynamics [24]. Here is a mechanism whereby hepatic perfusion pressure and
hepatic blood flow are linked to blood volume. In the relatively passive hepatic
sinusoidal bed, changes in perfusion pressure may alter both volume and distribution
of portal flow (see section 4). Reduced perfusion favors flow through low resistance
paths and divorces high resistance areas from portal inflow, forcing them to rely more
on hepatic arterial perfusion with its lesser content of nutrients and hepatotropic
factors. Conversely, higher portal perfusion pressures might expand the area of
portal perfusion and encourage hypertrophy, hyperplasia, and survival of marginal
hepatocytes and acini.
In the presence of esophagogastric varices with the accompanying risk of hemor-
rhage, an excessive increase in vascular volume with its attendant increase in portal
pressure presents a hazard. This risk must be balanced against the need in the
individual patient for an optimal hepatic environment to encourage improved cellu-
lar function and regeneration. Blood volume and portal pressure should, ideally, be
monitored during clinical management and an appropriate balance achieved [23].
7. Portal-Systemic Collateral Venous Network: The prominent portal-systemic
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collateral venous network of portal hypertension arises from preformed vascular
anastomoses at sites where the portal and caval systems are embryologically juxta-
posed. Rarely an anomalous situation exists where the portal vein or one of its
tributaries terminates directly in the caval system. Fine existing portal systemic
collaterals are expanded by increasing portal pressure [25]. With long-standing,
severe portal hypertension an increasing quantity of portal venous flow is diverted
into these collaterals and bypasses the liver to enter the systemic circulation [26]. In
advanced cirrhosis most of the portal blood is shunted around the liver [26]. Since
portal flow constitutes 20% or less ofcardiac output, the mixing ofportal blood with
systemic blood deprives the liver of the opportunity to extract nutrients in full
concentration, and forces it to do so only after they have been diluted fivefold.
Furthermore, specific metabolites such as tryptophan or insulin, present in low
concentrations in portal blood, may be lost to the liver completely when they are
altered or utilized by competingtissues. The loss ofthis "first pass" phenomenon is, in
a sense, the loss of a golden metabolic opportunity.
Although portal systemic collaterals do not usually divert a sufficient volume of
portal flow to reduce portal pressure in cirrhosis [27], occasionally a large collateral
circulation will reduce portal pressure to near normal levels [28]. This may be a
consequence ofan unusually large collateral capacityforflow diversion. The capacity
for diversion of portal flow through preformed collaterals is determined not only by
the diameter, length and tortuosity ofthe collaterals, but by the resistance to flow at
the stoma where the portal and caval vessels join. Presumably, these junctions are
usually small and restrictive. The diameter of portal collaterals is proportional to the
height of portal pressure [7]. Current evidence suggests that the quantity of portal
flow diverted is not a simple function of portal pressure, since cirrhotic patients with
similar portal pressures have widely differing quantities of portal flow traversing the
portal vein [26]. It would, therefore, appear that additional factors influence the
capacity of collaterals to divert portal flow. Perhaps, sustained, severe portal hyper-
tension forces anastomotic stomata open. On the other hand, the size of these
connections may be determined at theirembryological formation as are the collateral
vessels themselves [25]. In that case, different individuals would have differing
capacities for diversion of portal flow from the liver.
8. Potential Influence of Portal-Systemic Collateral Flow on the Evolution of
Liver Injury: At the extremes of a hypothetical continuum, the patient with small
high resistance anastomoses between portal and caval beds would retain portal flow
to the liver despite the presence of portal hypertension. The maintenance of portal
perfusion would favor hepatic regeneration and hypertrophy bycontinuing to supply
the damaged liver with concentrated nutrients and hepatotropic factors. This situa-
tion could favor the development of the large cirrhotic liver (hypertrophiccirrhosis).
On the other hand, the presence of a high volume portal-systemic collateral runoff
would deprive the injured hapatic parenchyma of portal factors and intensify the
consequences of hepatic injury. A small cirrhotic liver largely supplied by arterial
blood (atrophic cirrhosis) might result [29].
Current surgical approaches to the control of bleeding from esophagogastric
varices emphasize the preservation of portal flow to the liver [30]. In fact, these
technics may increase the portal fraction ofhepatic blood flow since they include the
intentional interruption of large portal-systemic collateral vessels [31]. Sophisticated
angiographic technics also allow selective obliterative thrombosis of large portal-
systemic collaterals by percutaneous or umbilical venous routes to reduce the risk of
variceal hemorrhage and redivert portal nutrients and hepatotropic factors to the
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liver [32]. The potential importance of portal flow to the liver emphasizes the subtle
but possibly detrimental effects ofdiurectic induced hypovolemia and its accompany-
ing reduction in portal pressure [33]. In addition, the current popularity ofparenteral
alimentation detracts from the essential unique consequences of the portal route of
hepatic nutrition [34].
The quantity and quality of hepatic perfusion is intimately related to the mainte-
nance of hepatocellular mass and function. In acute liver injury we aim to stimulate
restoration of parenchymal mass around an intact vasculature. To protect the
damaged organ and encourage maximumfunction, adequate stimuli for regeneration
and cellular hypertrophy must be supplied. Portal venous blood is unique in provid-
ing these stimuli in the form of as yet poorly defined hepatotropic factors and high
concentrations of exogenous and gut derived nutrients [35,36]. It, therefore, seems
reasonable to assume that in liver disease maintenance ofadequate portal flow to the
liver is required if maximum function be preserved. Diversion of portal flow from
individual acini and the liver as a whole recapitulates the prenatal state (Table 1), in
which the liver is deprived of digested nutrients [37].
The quantitative validation of these hypotheses will require the measurement of
hepatic arterial and portal fractions of hepatic blood flow, portal-systemic collateral
flow, functional hepatic parenchymal mass [29] and the response ofthese factors to
the manipulations proposed. There are numerous other factors active in the initiation
and perpetuation of hepatic injury. Nevertheless, these other pathogenetic mechan-
isms may be modulated by the hepatic vascular response to hepatic injury.
CONCLUSION
The anatomic and physiologic characteristics of the hepatic circulation influence
the severity and consequences ofhepatic injury. An understanding ofthe evolution of
hepatic vascular changes in liver disease may provide methods for estimating the
magnitude of liver injury and predicting its course. Where the inherent hepatic
vascular response is inappropriate or injurious, specific therapeutic countermeasures
may be possible.
ACKNOWLEDGEMENT
I wish to acknowledge the encouragement of Dr. Harold Conn who stimulated the writing ofthis paper and to thank
Dr. A.M. Rappaport for his kind contribution of Figs. 2 and 3 and the development of the acinar concept of hepatic
physiology on which the majority of the thinking in this paper is based. I also wish to express my appreciation to Miss
Rubell Smith for her excellent secretarial contribution.
REFERENCES
1. Burchell AR, Moreno AH, Panke WF, et al: Hepatic artery flow improvement after portacaval shunt. Ann Surg
184:289-302, 1976
2. Tygstrup N, Winkler K, Mellemgaard K, et al: Determination ofthe hepatic arterial blood flow and oxygen supply in
man by clamping the hepatic artery during surgery. J Clin Invest 41:447-454, 1962
3. Price JB, Jr, Voorhees AB, Britton RC: Operative hemodynamic studies in portal hypertension. Arch Surg
95:843-851, 1967
4. Starzl TE, Putnam CW, Porter KA, et al: Portal diversion for the treatment ofglycogen storage disease in humans.
Ann Surg 178:525-539, 1973
5. Starzl TE, Putnam CW, Chase HP, et al: Portacaval shunt in hyperlipoproteinaemia. Lancet 2:940-944, 1973
6. Mays ET, Wheeler CS: Demonstration of collateral arterial flow after interruption of hepatic arteries in man. New
Eng J Med 290:993-996, 1974
7. Joly JG, Marleau D, Legare AA, et al: Bleeding from esophageal varices in cirrhosis ofthe liver. Canad Med Assoc J
104:576-580, 1971
8. Lundbergh P, Strandell T: The effect ofphysical exercise on the wedged and free hepatic venous pressure in normal
men. Acta Med Scand 194:211-214, 1973506 DAVID S. ZIMMON
9. Rappaport AM, Knoblauch M, Black RG, et al: Hepatic microcirculatory changes leading to portal hypertension.
Ann NY Acad Sci 170:48-53, 1970
10. Brauer RW: Hepatic blood flow and its relation to hepatic function. Amer J Dig Dis 8:564-576, 1963
11. Popper H: Implications of portal hepatotropic factors in hepatology. Gastroent 66:1227-1233, 1974
12. McGee JO'D, O'Hare RP, Patrick RS: Stimulation of the collagen biosynthetic pathway by factors isolated from
experimentally-injured liver. Nature New Biol 243:121-122, 1973
13. Strandell T, Wrwald R, Kulling GK, et al: Regional variation in hepatic blood flow and function in man. Acta Med
Scand 194:215-218, 1973
14. Strandell T, Erwald R, Lundbergh P, et al: Estimations of lobar hepatic blood flows and extractions in severe liver
cirrhosis. Acta Med Scand 194:219-220, 1973
15. Cain GD, Mayer G, Jones EA: Augmentation ofalbumin but not fibrinogen synthesis by corticosteroids in patients
with hepatocellular disease. J Clin Invest 49:2198-2204, 1970
16. Juhl E, Winkel P, Tygstrup N, et al: Sex, ascites and alcoholism in survival of patients with cirrhosis: Effect of
prednisone. New Eng J Med 291:271-273, 1974
17. Winkler K, Larsen JA, Munker T, et al: Determination of the hepatic blood flow in man by simultaneous use offive
test substances measured in two parts of the liver. Scand J Clin & Lab Invest 17:423-432, 1965
18. Stenson RE, Constantino RT, Harrison DC: Interrelationships of hepatic blood flow, cardiac output, and blood
levels of lidocaine in man. Circulation 43:205-212, 1971
19. McDermott WV, Jr, Adams RD: Episodic stupor associated with an eck fistula in the human with particular
reference to the metabolism of ammonia. J Clin Invest 33:1-9, 1954
20. Koenemann LC, Ceballos R: Massive hepatic necrosis following portacaval shunt. JAMA 198:158-162, 1966
21. Conn HO, Lindenmuth WW, May CJ, et al: Prophylactic portacaval anastomosis. Medicine 51:27-40, 1972
22. Redeker AG, Geller HM, Reynolds TB: Hepatic wedged pressure, blood flow, vascular resistance and oxygen
consumption before and after end-to-side portacaval shunt. J Clin Invest 37:606-618, 1958
23. Zimmon DS, Kessler RE: The portal pressure-blood volume relationship in cirrhosis. Gut 15:99-101, 1974
24. Bradley SE: Circulation and the liver. Gastroent 44:403-409, 1963
25. Edwards EA: Functional anatomy of the porta-systemic communications. Arch Int Med 88:137-154, 1951
26. Moreno AH, Burchell AR, Rousselot LM, et.al: Portal blood flow in cirrhosis ofthe liver. J Clin Invest 46:436-445,
1967
27. Rousselot LM, Moreno AH, Panke WF: Studies on portal hypertension. IV. The clinical and physiopathologic
significance of self-established portal systemic venous shunts. Ann Surg 150:384-412, 1959
28. Sherlock S: The effect of a large portal-systemic collateral circulation in man. Washington, D.C.: Symposium on
Liver Function, American Institute of Biological Sciences, Publication #4, 1958, pp 495-508
29. Bircher J, Blankart R, Halpern A, et al: Criteria for assessment offunctional impairment inpatients withcirrhosis of
the liver. Europ J Clin Invest 3:72-85, 1973
30. Salam AA, Warren WD, LePage JR, et al: Hemodynamic contrasts between selective and total portal-systemic
decompression. Ann Surg 173:827-844, 1971
31. Zimmon DS, Kessler RE: Regulation of portal pressure in man. Gastroent 60:196, 1971 (Abstract)
32. Lunderquist A, Vang J: Transhepatic catheterization and obliteration of the coronary vein in patients with portal
hypertension and esophageal varices. New Eng J Med 291:646-649, 1974
33. Bradley SE: Clinical aspects of hepatic vascular physiology. IX Josiah Macy Conference on Liver Injury, 1950, pp
71-90
34. Monro HN: Free amino acid pools and their role in regulation. Mammalian Protein Synthesis. New York: Academic
Press, 1970, p 299
35. Starzl TE, Frakcavilla A, Halgrimson CG, et al: The origin, hormonal nature, and action of portal venous hepato-
tropic substances in portal venous blood. Surg Gyn & Obst 137:179-199, 1973
36. Ozawa K, Kitamura 0, Yamaoka T, et al: Metabolic responses ofthe liver of human beings and other mammals to
deprivation of portal blood supply. Surg Gyn & Obst 137:623-628, 1973
37. Zimmon DS: Hepatic blood flow and protein synthesis. Alcohol and Abnormal Protein Biosynthesis: Biochemical
and Clinical. Edited by MA Rothschild, M Oratz, S Schreiber. New York: Pergamon Press, 1975, pp 393-401
David S. Zimmon, M.D.
Department of Medicine
Gastroenterology Section
Veterans Administration Hospital
408 First Avenue
New York, New York 10010